Empirical Finance, LLC Emergent Bio Solutions Inc. Transaction History

Empirical Finance, LLC

  • $1.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$27.42 - $43.63 $206,883 - $329,188
-7,545 Closed
0 $0
Q4 2021

Feb 04, 2022
SELL
$33.11 - $55.01 $216,473 - $359,655
-6,538 Reduced 46.42%
7,545 $328,000
Q2 2021

Aug 10, 2021
BUY
$56.61 - $80.46 $797,238 - $1.13 Million
14,083 New
14,083 $887,000

Others Institutions Holding EBS

# of Institutions
160
Shares Held
33.8M
Call Options Held
453K
Put Options Held
931K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $512M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email